APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transpiration Inhibitor

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Transpiration Inhibitor Market Outlook and Growth Opportunities 2026

25 December 2025194 pages

Choose your research edition.

Industry ResearchTranspiration Inhibitor Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Transpiration Inhibitor Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Transpiration Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transpiration Inhibitor Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Transpiration Inhibitor Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Transpiration Inhibitor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Transpiration Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Transpiration Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transpiration Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Transpiration Inhibitor market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Transpiration Inhibitor market include Sumi Agro, Shanghai Zhilv, Zhengzhou Love Parker Chemical, ADAMA, Aquatrols, Coastal AgroBusiness, Wilbur-Ellis, AGROBEST AUSTRALIA and PBI-Gordon Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Transpiration Inhibitor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transpiration Inhibitor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transpiration Inhibitor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transpiration Inhibitor market size, projected growth trends, production technologies, key applications, and end-use industries.

Transpiration Inhibitor Segment by Company

Sumi Agro

Shanghai Zhilv

Zhengzhou Love Parker Chemical

ADAMA

Aquatrols

Coastal AgroBusiness

Wilbur-Ellis

AGROBEST AUSTRALIA

PBI-Gordon Corporation

Bonide

Wilt-Pruf Products

Transpiration Inhibitor Segment by Type

Mineral Oil

Synthetic Polymer

Transpiration Inhibitor Segment by Application

Residential

Garden

Others

Transpiration Inhibitor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Transpiration Inhibitor status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Transpiration Inhibitor market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Transpiration Inhibitor significant trends, drivers, influence factors in global and regions.

6. To analyze Transpiration Inhibitor competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transpiration Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transpiration Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transpiration Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transpiration Inhibitor market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transpiration Inhibitor industry.

Chapter 3: Detailed analysis of Transpiration Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Transpiration Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Transpiration Inhibitor in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Transpiration Inhibitor Industry Trends Table 2. Transpiration Inhibitor Industry Drivers Table 3. Transpiration Inhibitor Industry Opportunities and Challenges Table 4. Transpiration Inhibitor Industry Restraints Table 5. Global Transpiration Inhibitor Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Transpiration Inhibitor Revenue Share by Company (2021-2026) Table 7. Global Transpiration Inhibitor Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Transpiration Inhibitor Sales Volume Share by Company (2021-2026) Table 9. Global Transpiration Inhibitor Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Transpiration Inhibitor Company Ranking, (2024-2026) & (USD Million) Table 11. Global Transpiration Inhibitor Key Company Manufacturing Base & Headquarters Table 12. Global Transpiration Inhibitor Company, Product Type & Application Table 13. Global Transpiration Inhibitor Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Transpiration Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Mineral Oil Table 18. Significant Companies of Synthetic Polymer Table 19. Global Transpiration Inhibitor Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Transpiration Inhibitor Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Transpiration Inhibitor Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Transpiration Inhibitor Sales Volume Share by Type (2021-2026) Table 23. Global Transpiration Inhibitor Sales Volume Share by Type (2027-2032) Table 24. Global Transpiration Inhibitor Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Transpiration Inhibitor Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Transpiration Inhibitor Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Transpiration Inhibitor Sales Value Share by Type (2021-2026) Table 28. Global Transpiration Inhibitor Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Residential Table 30. Significant Companies of Garden Table 31. Significant Companies of Others Table 32. Global Transpiration Inhibitor Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global Transpiration Inhibitor Sales Volume by Application (2021-2026) & (Tons) Table 34. Global Transpiration Inhibitor Sales Volume by Application (2027-2032) & (Tons) Table 35. Global Transpiration Inhibitor Sales Volume Share by Application (2021-2026) Table 36. Global Transpiration Inhibitor Sales Volume Share by Application (2027-2032) Table 37. Global Transpiration Inhibitor Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Transpiration Inhibitor Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Transpiration Inhibitor Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Transpiration Inhibitor Sales Value Share by Application (2021-2026) Table 41. Global Transpiration Inhibitor Sales Value Share by Application (2027-2032) Table 42. Global Transpiration Inhibitor Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 43. Global Transpiration Inhibitor Sales by Region (2021-2026) & (Tons) Table 44. Global Transpiration Inhibitor Sales Market Share by Region (2021-2026) Table 45. Global Transpiration Inhibitor Sales by Region (2027-2032) & (Tons) Table 46. Global Transpiration Inhibitor Sales Market Share by Region (2027-2032) Table 47. Global Transpiration Inhibitor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Transpiration Inhibitor Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Transpiration Inhibitor Sales Value Share by Region (2021-2026) Table 50. Global Transpiration Inhibitor Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Transpiration Inhibitor Sales Value Share by Region (2027-2032) Table 52. Global Transpiration Inhibitor Market Average Price (US$/Ton) by Region (2021-2026) Table 53. Global Transpiration Inhibitor Market Average Price (US$/Ton) by Region (2027-2032) Table 54. Global Transpiration Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. Global Transpiration Inhibitor Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Transpiration Inhibitor Sales by Country (2021-2026) & (Tons) Table 57. Global Transpiration Inhibitor Sales Market Share by Country (2021-2026) Table 58. Global Transpiration Inhibitor Sales by Country (2027-2032) & (Tons) Table 59. Global Transpiration Inhibitor Sales Market Share by Country (2027-2032) Table 60. Global Transpiration Inhibitor Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Transpiration Inhibitor Sales Value Market Share by Country (2021-2026) Table 62. Global Transpiration Inhibitor Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Transpiration Inhibitor Sales Value Market Share by Country (2027-2032) Table 64. Sumi Agro Company Information Table 65. Sumi Agro Business Overview Table 66. Sumi Agro Transpiration Inhibitor Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 67. Sumi Agro Transpiration Inhibitor Product Portfolio Table 68. Sumi Agro Recent Development Table 69. Shanghai Zhilv Company Information Table 70. Shanghai Zhilv Business Overview Table 71. Shanghai Zhilv Transpiration Inhibitor Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 72. Shanghai Zhilv Transpiration Inhibitor Product Portfolio Table 73. Shanghai Zhilv Recent Development Table 74. Zhengzhou Love Parker Chemical Company Information Table 75. Zhengzhou Love Parker Chemical Business Overview Table 76. Zhengzhou Love Parker Chemical Transpiration Inhibitor Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. Zhengzhou Love Parker Chemical Transpiration Inhibitor Product Portfolio Table 78. Zhengzhou Love Parker Chemical Recent Development Table 79. ADAMA Company Information Table 80. ADAMA Business Overview Table 81. ADAMA Transpiration Inhibitor Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. ADAMA Transpiration Inhibitor Product Portfolio Table 83. ADAMA Recent Development Table 84. Aquatrols Company Information Table 85. Aquatrols Business Overview Table 86. Aquatrols Transpiration Inhibitor Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Aquatrols Transpiration Inhibitor Product Portfolio Table 88. Aquatrols Recent Development Table 89. Coastal AgroBusiness Company Information Table 90. Coastal AgroBusiness Business Overview Table 91. Coastal AgroBusiness Transpiration Inhibitor Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. Coastal AgroBusiness Transpiration Inhibitor Product Portfolio Table 93. Coastal AgroBusiness Recent Development Table 94. Wilbur-Ellis Company Information Table 95. Wilbur-Ellis Business Overview Table 96. Wilbur-Ellis Transpiration Inhibitor Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. Wilbur-Ellis Transpiration Inhibitor Product Portfolio Table 98. Wilbur-Ellis Recent Development Table 99. AGROBEST AUSTRALIA Company Information Table 100. AGROBEST AUSTRALIA Business Overview Table 101. AGROBEST AUSTRALIA Transpiration Inhibitor Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 102. AGROBEST AUSTRALIA Transpiration Inhibitor Product Portfolio Table 103. AGROBEST AUSTRALIA Recent Development Table 104. PBI-Gordon Corporation Company Information Table 105. PBI-Gordon Corporation Business Overview Table 106. PBI-Gordon Corporation Transpiration Inhibitor Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 107. PBI-Gordon Corporation Transpiration Inhibitor Product Portfolio Table 108. PBI-Gordon Corporation Recent Development Table 109. Bonide Company Information Table 110. Bonide Business Overview Table 111. Bonide Transpiration Inhibitor Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 112. Bonide Transpiration Inhibitor Product Portfolio Table 113. Bonide Recent Development Table 114. Wilt-Pruf Products Company Information Table 115. Wilt-Pruf Products Business Overview Table 116. Wilt-Pruf Products Transpiration Inhibitor Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 117. Wilt-Pruf Products Transpiration Inhibitor Product Portfolio Table 118. Wilt-Pruf Products Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Transpiration Inhibitor Distributors List Table 122. Transpiration Inhibitor Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Transpiration Inhibitor Product Image Figure 2. Global Transpiration Inhibitor Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transpiration Inhibitor Sales Value (2021-2032) & (US$ Million) Figure 4. Global Transpiration Inhibitor Sales (2021-2032) & (Tons) Figure 5. Global Transpiration Inhibitor Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Transpiration Inhibitor Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Mineral Oil Image Figure 10. Synthetic Polymer Image Figure 11. Global Transpiration Inhibitor Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Transpiration Inhibitor Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Transpiration Inhibitor Sales Volume Share by Type (2021-2032) Figure 14. Global Transpiration Inhibitor Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Transpiration Inhibitor Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Transpiration Inhibitor Sales Value Share by Type (2021-2032) Figure 17. Residential Image Figure 18. Garden Image Figure 19. Others Image Figure 20. Global Transpiration Inhibitor Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 21. Global Transpiration Inhibitor Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Transpiration Inhibitor Sales Volume Share by Application (2021-2032) Figure 23. Global Transpiration Inhibitor Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Transpiration Inhibitor Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Transpiration Inhibitor Sales Value Share by Application (2021-2032) Figure 26. Global Transpiration Inhibitor Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 27. Global Transpiration Inhibitor Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Transpiration Inhibitor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Transpiration Inhibitor Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Transpiration Inhibitor Sales Value (2021-2032) & (US$ Million) Figure 31. North America Transpiration Inhibitor Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Transpiration Inhibitor Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Transpiration Inhibitor Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Transpiration Inhibitor Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Transpiration Inhibitor Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Transpiration Inhibitor Sales Value (2021-2032) & (US$ Million) Figure 37. South America Transpiration Inhibitor Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Transpiration Inhibitor Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Transpiration Inhibitor Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Transpiration Inhibitor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Transpiration Inhibitor Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Transpiration Inhibitor Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Mineral Oil
  • Synthetic Polymer
Applications
  • Residential
  • Garden
  • Others
Companies covered
  • Sumi Agro
  • Shanghai Zhilv
  • Zhengzhou Love Parker Chemical
  • ADAMA
  • Aquatrols
  • Coastal AgroBusiness
  • Wilbur-Ellis
  • AGROBEST AUSTRALIA
  • PBI-Gordon Corporation
  • Bonide
  • Wilt-Pruf Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Transpiration Inhibitor Sales Value (2021-2032)
  4. 1.2.2 Global Transpiration Inhibitor Sales Volume (2021-2032)
  5. 1.2.3 Global Transpiration Inhibitor Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Transpiration Inhibitor Market Dynamics
  1. 2.1 Transpiration Inhibitor Industry Trends
  2. 2.2 Transpiration Inhibitor Industry Drivers
  3. 2.3 Transpiration Inhibitor Industry Opportunities and Challenges
  4. 2.4 Transpiration Inhibitor Industry Restraints
3 Transpiration Inhibitor Market by Company
  1. 3.1 Global Transpiration Inhibitor Company Revenue Ranking in 2025
  2. 3.2 Global Transpiration Inhibitor Revenue by Company (2021-2026)
  3. 3.3 Global Transpiration Inhibitor Sales Volume by Company (2021-2026)
  4. 3.4 Global Transpiration Inhibitor Average Price by Company (2021-2026)
  5. 3.5 Global Transpiration Inhibitor Company Ranking (2024-2026)
  6. 3.6 Global Transpiration Inhibitor Company Manufacturing Base and Headquarters
  7. 3.7 Global Transpiration Inhibitor Company Product Type and Application
  8. 3.8 Global Transpiration Inhibitor Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Transpiration Inhibitor Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Transpiration Inhibitor Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Transpiration Inhibitor Market by Type
  1. 4.1 Transpiration Inhibitor Type Introduction
  2. 4.1.1 Mineral Oil
  3. 4.1.2 Synthetic Polymer
  4. 4.2 Global Transpiration Inhibitor Sales Volume by Type
  5. 4.2.1 Global Transpiration Inhibitor Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Transpiration Inhibitor Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Transpiration Inhibitor Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Transpiration Inhibitor Sales Value by Type
  9. 4.3.1 Global Transpiration Inhibitor Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Transpiration Inhibitor Sales Value by Type (2021-2032)
  11. 4.3.3 Global Transpiration Inhibitor Sales Value Share by Type (2021-2032)
5 Transpiration Inhibitor Market by Application
  1. 5.1 Transpiration Inhibitor Application Introduction
  2. 5.1.1 Residential
  3. 5.1.2 Garden
  4. 5.1.3 Others
  5. 5.2 Global Transpiration Inhibitor Sales Volume by Application
  6. 5.2.1 Global Transpiration Inhibitor Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Transpiration Inhibitor Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Transpiration Inhibitor Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Transpiration Inhibitor Sales Value by Application
  10. 5.3.1 Global Transpiration Inhibitor Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Transpiration Inhibitor Sales Value by Application (2021-2032)
  12. 5.3.3 Global Transpiration Inhibitor Sales Value Share by Application (2021-2032)
6 Transpiration Inhibitor Regional Sales and Value Analysis
  1. 6.1 Global Transpiration Inhibitor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transpiration Inhibitor Sales by Region (2021-2032)
  3. 6.2.1 Global Transpiration Inhibitor Sales by Region: 2021-2026
  4. 6.2.2 Global Transpiration Inhibitor Sales by Region (2027-2032)
  5. 6.3 Global Transpiration Inhibitor Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Transpiration Inhibitor Sales Value by Region (2021-2032)
  7. 6.4.1 Global Transpiration Inhibitor Sales Value by Region: 2021-2026
  8. 6.4.2 Global Transpiration Inhibitor Sales Value by Region (2027-2032)
  9. 6.5 Global Transpiration Inhibitor Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Transpiration Inhibitor Sales Value (2021-2032)
  12. 6.6.2 North America Transpiration Inhibitor Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Transpiration Inhibitor Sales Value (2021-2032)
  15. 6.7.2 Europe Transpiration Inhibitor Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Transpiration Inhibitor Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Transpiration Inhibitor Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Transpiration Inhibitor Sales Value (2021-2032)
  21. 6.9.2 South America Transpiration Inhibitor Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Transpiration Inhibitor Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Transpiration Inhibitor Sales Value Share by Country, 2025 VS 2032
7 Transpiration Inhibitor Country-level Sales and Value Analysis
  1. 7.1 Global Transpiration Inhibitor Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Transpiration Inhibitor Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Transpiration Inhibitor Sales by Country (2021-2032)
  4. 7.3.1 Global Transpiration Inhibitor Sales by Country (2021-2026)
  5. 7.3.2 Global Transpiration Inhibitor Sales by Country (2027-2032)
  6. 7.4 Global Transpiration Inhibitor Sales Value by Country (2021-2032)
  7. 7.4.1 Global Transpiration Inhibitor Sales Value by Country (2021-2026)
  8. 7.4.2 Global Transpiration Inhibitor Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Transpiration Inhibitor Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Transpiration Inhibitor Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Transpiration Inhibitor Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sumi Agro
  2. 8.1.1 Sumi Agro Company Information
  3. 8.1.2 Sumi Agro Business Overview
  4. 8.1.3 Sumi Agro Transpiration Inhibitor Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sumi Agro Transpiration Inhibitor Product Portfolio
  6. 8.1.5 Sumi Agro Recent Developments
  7. 8.2 Shanghai Zhilv
  8. 8.2.1 Shanghai Zhilv Company Information
  9. 8.2.2 Shanghai Zhilv Business Overview
  10. 8.2.3 Shanghai Zhilv Transpiration Inhibitor Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Zhilv Transpiration Inhibitor Product Portfolio
  12. 8.2.5 Shanghai Zhilv Recent Developments
  13. 8.3 Zhengzhou Love Parker Chemical
  14. 8.3.1 Zhengzhou Love Parker Chemical Company Information
  15. 8.3.2 Zhengzhou Love Parker Chemical Business Overview
  16. 8.3.3 Zhengzhou Love Parker Chemical Transpiration Inhibitor Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Zhengzhou Love Parker Chemical Transpiration Inhibitor Product Portfolio
  18. 8.3.5 Zhengzhou Love Parker Chemical Recent Developments
  19. 8.4 ADAMA
  20. 8.4.1 ADAMA Company Information
  21. 8.4.2 ADAMA Business Overview
  22. 8.4.3 ADAMA Transpiration Inhibitor Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 ADAMA Transpiration Inhibitor Product Portfolio
  24. 8.4.5 ADAMA Recent Developments
  25. 8.5 Aquatrols
  26. 8.5.1 Aquatrols Company Information
  27. 8.5.2 Aquatrols Business Overview
  28. 8.5.3 Aquatrols Transpiration Inhibitor Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Aquatrols Transpiration Inhibitor Product Portfolio
  30. 8.5.5 Aquatrols Recent Developments
  31. 8.6 Coastal AgroBusiness
  32. 8.6.1 Coastal AgroBusiness Company Information
  33. 8.6.2 Coastal AgroBusiness Business Overview
  34. 8.6.3 Coastal AgroBusiness Transpiration Inhibitor Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Coastal AgroBusiness Transpiration Inhibitor Product Portfolio
  36. 8.6.5 Coastal AgroBusiness Recent Developments
  37. 8.7 Wilbur-Ellis
  38. 8.7.1 Wilbur-Ellis Company Information
  39. 8.7.2 Wilbur-Ellis Business Overview
  40. 8.7.3 Wilbur-Ellis Transpiration Inhibitor Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Wilbur-Ellis Transpiration Inhibitor Product Portfolio
  42. 8.7.5 Wilbur-Ellis Recent Developments
  43. 8.8 AGROBEST AUSTRALIA
  44. 8.8.1 AGROBEST AUSTRALIA Company Information
  45. 8.8.2 AGROBEST AUSTRALIA Business Overview
  46. 8.8.3 AGROBEST AUSTRALIA Transpiration Inhibitor Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 AGROBEST AUSTRALIA Transpiration Inhibitor Product Portfolio
  48. 8.8.5 AGROBEST AUSTRALIA Recent Developments
  49. 8.9 PBI-Gordon Corporation
  50. 8.9.1 PBI-Gordon Corporation Company Information
  51. 8.9.2 PBI-Gordon Corporation Business Overview
  52. 8.9.3 PBI-Gordon Corporation Transpiration Inhibitor Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 PBI-Gordon Corporation Transpiration Inhibitor Product Portfolio
  54. 8.9.5 PBI-Gordon Corporation Recent Developments
  55. 8.10 Bonide
  56. 8.10.1 Bonide Company Information
  57. 8.10.2 Bonide Business Overview
  58. 8.10.3 Bonide Transpiration Inhibitor Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Bonide Transpiration Inhibitor Product Portfolio
  60. 8.10.5 Bonide Recent Developments
  61. 8.11 Wilt-Pruf Products
  62. 8.11.1 Wilt-Pruf Products Company Information
  63. 8.11.2 Wilt-Pruf Products Business Overview
  64. 8.11.3 Wilt-Pruf Products Transpiration Inhibitor Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Wilt-Pruf Products Transpiration Inhibitor Product Portfolio
  66. 8.11.5 Wilt-Pruf Products Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Transpiration Inhibitor Value Chain Analysis
  2. 9.1.1 Transpiration Inhibitor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Transpiration Inhibitor Sales Mode & Process
  6. 9.2 Transpiration Inhibitor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Transpiration Inhibitor Distributors
  9. 9.2.3 Transpiration Inhibitor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst